CA Patent

CA2878699C — Process and intermediates for preparing integrase inhibitors

Assigned to Gilead Sciences Inc · Expires 2018-09-11 · 8y expired

What this patent protects

The invention provides synthetic processes and synthetic intermediates that can be used to prepare 4-oxoquinolone compounds such as compound 13 having integrase inhibiting properties. Synthetic intermediates include compounds 5 and 8. (see compounds 5, 8 and 13)

USPTO Abstract

The invention provides synthetic processes and synthetic intermediates that can be used to prepare 4-oxoquinolone compounds such as compound 13 having integrase inhibiting properties. Synthetic intermediates include compounds 5 and 8. (see compounds 5, 8 and 13)

Drugs covered by this patent

Patent Metadata

Patent number
CA2878699C
Jurisdiction
CA
Classification
—
Expires
2018-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.